According to a new market report published by Transparency Market Research “Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019“ the global blood flow measurement devices market was valued at USD 0.27 billion in 2012 and expected to grow at a CAGR of 8.7% from 2013 to 2019, to reach an estimated value of USD 0.50 Billion in 2019.
Browse Blood Flow Measurement Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/blood-flow-measurement-devices.html
Blood flow measurement devices are primarily used for measurement of volume rate of blood flow for diagnosis of disorders and diseases. The volume rate of blood flow is defined as the amount of blood passing through a cross section of a blood vessel per unit time. Rise in incidence rate of individuals suffering peripheral vascular diseases and growing geriatric population are some of the factors fuelling the growth of this market. According to the statistical data provided by the Centers for Disease Control and Prevention (CDC) in the year 2012, approximately 8,000,000 people in the United States were diagnosed with peripheral arterial disease; that includes 12-20% of population older than 60 years of age. Similarly, increasing clinical applications of blood flow devices is another factor which is likely to trigger the market growth.
Blood flow measurement devices have a wide range of clinical applications varying from diabetes, dermatology, tumor monitoring, intra cranial monitoring, gastroenterology to peripheral vascular diseases. Among all of the above mentioned clinical applications, peripheral vascular diseases accounted for the largest market share (approximately 27.8%) in 2012. Moreover, the disease is expected to show the highest growth rate reporting a CAGR of 11.3% during the forecast period 2013-2019. The growth in this segment is attributed to rise in the number of obese population coupled with the increasing risk of cardiovascular and circulatory diseases. Intra-cranial monitoring and tumor monitoring are also expected to witness significant growth during the forecast period.
Ultrasonic Doppler blood flow meters accounted for the largest share of the market in 2012 and are poised to grow at a CAGR of 10.7% from 2013-2019. This growth rate is anticipated owing to innovations in technology and rise in the number of clinical applications. Moreover, recent developments in Ultrasonic Doppler blood flow meters such as digital Doppler, multi-range Doppler technology and bilateral Doppler technology has paved a new path for the growth of this market. In addition, factors such as development of minimally invasive and non-invasive devices as well as rigorous R&D initiatives are expected to drive the global blood flow measurement devices market. Laser Doppler blood flow meter devices market is expected to decline due to high cost and a gradual decline in the number of clinical applications as compared to ultrasonic Doppler blood flow meters.
In terms of geography, North America is the leading geography for blood flow measurement devices market owing to rise in circulatory disorders and escalated health awareness. Emerging economies such as Latin America and Asia are expected to display significant growth prospects for the blood flow measurement devices market. Countries such as China, Russia, Brazil and India are expected to foresee a high growth for blood flow measurement devices owing to a large base of diabetic and geriatric population coupled with high prevalence of peripheral arterial diseases in these countries. However, stringent regulatory approvals coupled with high shipment costs of these devices could hinder market growth.
Some of the major companies involved in the production and commercialization of blood flow measurement devices are ArjoHuntleigh Inc., Deltex Medical, Transonic Systems Inc., Moor Instruments Ltd. and Cook Medical Inc., amongst others.
The global blood flow measurement devices market is segmented as follows:
Blood Flow Measurement Devices Market, by Product types
- Ultrasonic Doppler Blood Flowmeters
- Laser Doppler Blood Flowmeters
- Electromagnetic Blood Flowmeters
Blood Flow Measurement Devices Market, by Applications
- Diabetes Research
- Peripheral Vascular Diseases
- Intra-cranial Monitoring in Stroke and Brain Injury
Blood Flow Measurement Devices Market, by Geography
- North America
- Rest of the World (RoW)
Related & Recently Published Report by Transparency Market Research
Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.
The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders, oncology, HLA testing and pharmacogenetics testing. The infectious diseases segment comprises market for HIV infections, HAI, HCV infections and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.